WASHINGTON (AP) — An experimental drug might help slow early Alzheimer’s disease in a markedly different way than today’s treatments — by lowering levels of a brain protein called tau, researchers reported Tuesday. Tau is one part of a toxic duo fueling Alzheimer’s but prior attempts to develop drugs that can target the protein have [...]
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | An experimental Alzheimer's drug shows promise targeting a different brain protein, new study shows | 2 | 7 | 14-07-2026 |
| 2 | Scientists may have finally found how Alzheimer's spreads through the brain | 0 | 7.51 | 30-06-2026 |
| 3 | A little-known protein may be fueling Alzheimer’s — and scientists found a way to block it | 0 | 8.12 | 17-08-2026 |
| 4 | Alzheimer’s Breakthrough: Scientists Discover Key Protein May Prevent Toxic Protein Clumps in the Brain | 0 | 14.63 | 14-04-2026 |
| 5 | Scientists May Have Found What Really Triggers Alzheimer’s Disease | 2 | 7 | 19-06-2026 |
| 6 | Tau levels fall, cognitive decline slows with diranersen | 0 | 9.46 | 04-08-2026 |
| 7 | Scientists discover a protein that protects the brain from Alzheimer’s damage | 0 | 6.05 | 20-07-2026 |
| 8 | Valiltramiprosate lowers biomarkers in patients with Alzheimer’s | 0 | 12.23 | 03-08-2026 |
| 9 | Copper drug clears toxic Alzheimer’s proteins and restores memory | 0 | 9.29 | 15-06-2026 |
| 10 | Two new compounds could reveal hidden drivers of Alzheimer’s disease | 0 | 5.8 | 03-08-2026 |